Anzeige
Mehr »
Freitag, 22.08.2025 - Börsentäglich über 12.000 News
Übernahme-Kracher: Diese Übernahme eröffnet völlig neue Wachstumschancen im Krypto-Sektor
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
232 Leser
Artikel bewerten:
(1)

Renalogic Experiences Record Growth in 2023

Cost containment and care management company extends category leadership with new products and record savings for clients and their members.

CHICAGO, IL / ACCESSWIRE / February 21, 2024 / Renalogic, the market leader helping self-funded health plans and their members manage the human and financial costs of chronic kidney disease (CKD) and dialysis, today announced a year of continued growth and achievements.

In 2023, Renalogic welcomed nearly 100 new clients, accounting for more than 170,000 lives, the largest life growth in the company's history. New clients ranged from 50 to 50,000 plan members. All types of self-funded plans and industries were represented by these new clients, including Taft-Hartley plans, municipal plans, tribal nations and employer plans covering dozens of industries, including healthcare, transportation, schools, retail and financial services. Through these expanded relationships, Renalogic ended 2023 supporting the financial and clinical health of over 715,000 members in all 50 states.

During the year, Renalogic's cost-saving solutions saved clients more than $60 million and was also recertified by the Validation Institute as being a major cost-saver for self-funded plans throughout the U.S.

Renalogic also saw remarkable results in its clinical support of members, including:

  • 98.3% effective in preventing enrolled members from progressing to dialysis
  • 86.5% effective at preventing enrolled members from progressing from CKD4 to ESRD
  • 85.7% effective at preventing enrolled members from progressing from CKD5 to ESRD
  • 91% reduction in member ER visits
  • 89% reduction in member hospital admissions

"2023 was another great year for our clients, members, partners and employees," said Kevin Weinstein, CEO of Renalogic. "We helped thousands of members via our care management services and saved our clients and their members millions of dollars through cost containment services. While we are pleased with our 2023 business results, we're even more pleased with the level of impact we had on our members' lives."

The company also built upon its NPS (Net Promoter Score) of +83 among Broker/Consultant partners and expanded its ecosystem relationships with numerous channel partners, including third-party administrators (TPAs), benefits consulting firms and data analytics providers.

Renalogic also introduced a new complex claims cost containment solution - ImpactClarify. This solution seeks to unravel the complexity of multiple accountable party claims and go beyond basic subrogation. For those complex claims that may involve auto insurance coverage, workers' compensation, multiple health plans, and even tort settlements and charitable obligations, this expert-led service ensures that the right entity pays the right amount. ImpactClarify is a service for all payers, including all commercial plans, Medicare and Medicaid, and covers all types of claims, not just those related to kidney health.

"ImpactClarify is an extension of our expert-led cost containment efforts," said Weinstein. "This is our first step beyond the world of kidney health, and we're excited to bring this solution to existing and new clients."

For more information about Renalogic, visit renalogic.com.

About Renalogic?

Founded in 2002, Renalogic helps self-funded plans of all sizes and their U.S.-based health plan members reduce the human and financial costs of chronic kidney disease (CKD) and dialysis. We help organizations manage dialysis claims with cost-containment and transparency solutions while working to prevent members from progressing to dialysis with our care management programs. Renalogic has helped clients save hundreds of millions of dollars and helped stop CKD from progressing for thousands of members. Learn more at renalogic.com.?

Media Contact:

Nick Severino | SVP, Marketing | nseverino@renalogic.com

Contact Information:

Nick Severino
SVP, Marketing
marketing@renalogic.com

SOURCE: Renalogic

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.